dc.contributor.author | Pennant, M | |
dc.contributor.author | Takwoingi, Y | |
dc.contributor.author | Pennant, L | |
dc.contributor.author | Davenport, Clare | |
dc.contributor.author | Fry-Smith, A | |
dc.contributor.author | Eisinga, A | |
dc.contributor.author | Andronis, L | |
dc.contributor.author | Arvanitis, T | |
dc.contributor.author | Deeks, J | |
dc.contributor.author | Hyde, C | |
dc.date.accessioned | 2013-07-04T10:38:23Z | |
dc.date.issued | 2010-10 | |
dc.description.abstract | Breast cancer (BC) accounts for one-third of all cases of cancer in women in the UK. Current strategies for the detection of BC recurrence include computed tomography (CT), magnetic resonance imaging (MRI) and bone scintigraphy. Positron emission tomography (PET) and, more recently, positron emission tomography/computed tomography (PET/CT) are technologies that have been shown to have increasing relevance in the detection and management of BC recurrence. | en_GB |
dc.identifier.citation | Health Technology Assessment, 2010, Vol. 14, Issue 50, pp. 1 - 103 | en_GB |
dc.identifier.doi | 10.3310/hta14500 | |
dc.identifier.uri | http://hdl.handle.net/10871/11527 | |
dc.language.iso | en | en_GB |
dc.publisher | NIHR Health Technology Assessment Programme | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/21044553 | en_GB |
dc.relation.url | http://www.journalslibrary.nihr.ac.uk/hta/volume-14/issue-50 | en_GB |
dc.subject | Breast Neoplasms | en_GB |
dc.subject | Confidence Intervals | en_GB |
dc.subject | Female | en_GB |
dc.subject | Great Britain | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Neoplasm Recurrence, Local | en_GB |
dc.subject | Positron-Emission Tomography | en_GB |
dc.subject | Prognosis | en_GB |
dc.subject | ROC Curve | en_GB |
dc.subject | Risk Assessment | en_GB |
dc.subject | Sensitivity and Specificity | en_GB |
dc.subject | Tomography, X-Ray Computed | en_GB |
dc.title | A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2013-07-04T10:38:23Z | |
exeter.place-of-publication | England | |
dc.description | addresses: West Midlands Health Technology Assessment Collaboration, Unit of Public Health, Epidemiology & Biostatistics, University of Birmingham, Birmingham, UK. | en_GB |
dc.description | types: Journal Article; Research Support, N.I.H., Extramural; Review | en_GB |
dc.description | Published version. Copyright © 2010 NIHR Health Technology Assessment Programme | en_GB |
dc.identifier.journal | Health Technology Assessment | en_GB |